Browse studies

Find your next paid study

27,288 recruiting studies available now

Newest first Highest paying

Phase 1

Understanding Ketamine's Dissociative Effects in Epilepsy (KD Study)

The purpose of this study is to understand how ketamine brings about dissociative symptoms.

Epilepsy

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Stanford UniversityNCT04861051

Phase 2

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

To learn about the safety of a drug called axicabtagene ciloleucel given in combination with radiation therapy to patients with relapsed/refractory FL.

Follicular Lymphoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT06043323

Observational

A Novel Digital Platform for Measurement-based Peer Supervision of Non-specialist Providers Conducting Brief Psychological Interventions

The goal of this project is to enhance and evaluate the efficacy of a scalable digital solution designed to help train and support the work of non-specialist p…

Training of Mental Health ProfessionalsTraining of Frontline Health Workers

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Dimagi Inc.NCT07082010

Phase 1

MC1641 Phase II Study Of Intratumoral Injection Of Autologous Dendritic Cells Combined With Immune Checkpoint Inhibition After High-Dose Conformal External Beam Radiotherapy In Patients With Unresectable Primary Liver Cancer

This early phase I trial studies the side effects of autologous dendritic cells and a vaccine called Prevnar in combination with immune checkpoint inhibition (…

Stage III Hepatocellular Carcinoma AJCC v8Stage III Intrahepatic Cholangiocarcinoma AJCC v8Stage IV Hepatocellular Carcinoma AJCC v8+3 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Mayo Clinic

Phase 1

A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer Previously Exposed to PD-1/PD-L1 Treatment (KEYMAKER-U06): Substudy 06B

This is a Phase 1/2, multicenter, randomized, open-label umbrella platform study to evaluate the safety and efficacy of investigational agents with or without …

Esophageal Squamous Cell Carcinoma

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT05319730

Phase 2

Effects Of Nocturnal Dronabinol Use On Obstructive Sleep Apnea Treatment And Physiological Outcomes

The purpose of this study is to determine if oral dronabinol prior to sleep can improve CPAP adherence and sleep quality in humans. We also seek to determine i…

Obstructive Sleep Apnea

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Mayo ClinicNCT07570953

Observational

Non-Invasive Deep Brain Neuromodulation for Smoking Cessation

This study will develop novel low intensity focused ultrasound (LIFU) therapy to help people to quit cigarette smoking. Smoking is associated with cancers of t…

Nicotine Addiction

Estimated

~$10 – $750

Actual pay is set by the research site.

The University of Texas Health Science Center, HoustonNCT07298902

ROBOTIC MINIMALLY INVASIVE HYSTERECTOMY POST-MARKET CLINICAL STUDY WITH THE DEXTER ROBOTIC SURGERY SYSTEM

The purpose of this post-market, observational study is to collect real-world data under anticipated conditions of use that demonstrates that the device perfor…

Hysterectomy, Benign Uterine Diseases

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Distalmotion SANCT07746531

A Multicenter Screening Study to Characterize the Prevalence of the KIT D816V Mutation in Patients With Suspected Clonal Mast Cell Disease

This is a multicenter screening study to characterize the prevalence of the KIT D816V mutation in participants with suspected clonal mast cell disease.

Clonal Mast Cell DiseaseKIT D816V MutationSuspected KITD816V Mutated Clonal Mast Cell Disease

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Blueprint Medicines CorporationNCT07143669

Phase 2

A Phase 2 Study of Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway

A phase 2 study testing the efficacy of isotretinoin versus doxycycline in treating participants who develop a acneiform rash caused by standard of care, tumor…

Acneiform Drug EruptionAcneiform Eruptions

Estimated

~$75 – $1,800

Actual pay is set by the research site.

University of California, San FranciscoNCT07629167

Phase 1

A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

To learn the recommended dose of momelotinib that can be given in combination with gilteritinib to participants with AML.

Myeloid Leukemia

Estimated

~$150 – $3,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT06235801

Longitudinal Study of Intra-Uterine Growth Restriction (IUGR)

The investigation will employ a longitudinal approach in which every fetus diagnosed to be SGA (Small for Gestational Age ) will be studied at frequent interva…

IUGRPregnancy

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Colorado, DenverNCT02382601